Papilledema: Are we any nearer to a consensus on pathogenesis and treatment?

Current Neurology and Neuroscience Reports

Volumn 12, Issue 3, 2012, Pages 334-339

  Lee, Andrew G ^a,b,c,d   Wall, Michael ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cerebral venous sinus thrombosis; Idiopathic intracranial hypertension; Papilledema; Pseudotumor cerebri; Venous stenting; Visual loss

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; DIURETIC AGENT; FUROSEMIDE; TOPIRAMATE;

ARTICLE; BLOOD PRESSURE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID PRESSURE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FENESTRATION; HEADACHE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE; LUMBAR PERITONEAL SHUNT; LUMBAR PUNCTURE; OPTIC NERVE LESION; OPTIC NERVE SHEATH FENESTRATION; PAPILLEDEMA; PATHOGENESIS; PATIENT COMPLIANCE; REBOUND; RECOMMENDED DRUG DOSE; SIDE EFFECT; SODIUM RESTRICTION; STENT; TRANSVERSE SINUS STENOSIS STENTING; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; WEIGHT GAIN; WEIGHT REDUCTION;

HUMANS; INTRACRANIAL HYPERTENSION; PAPILLEDEMA; VISION DISORDERS;

EID: 84861229330     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-012-0257-8     Document Type: Article

References (49)

1. Orcutt JC, Page NG, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology. 1984;91:1303-12. (Pubitemid 15208896)
2. Grehn F, Knorr-Held S, Kommerell G. Glaucomatous like visual field defects in chronic papilledema. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981;217:99-109. (Pubitemid 11061841)
3. Wall M, White WN. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998;39(1):134-42. (Pubitemid 28040471)
4. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol. 1977;95:1553-65. (Pubitemid 8192934)
5. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155-80.
6. Kirkham TH, Sanders MD, Sapp GA. Unilateral papilloedema in benign intracranial hypertension. Can J Ophthalmol. 1973;8:533-8.
7. Muci-Mendoza R, Arruga J, Hoyt WF. Distension bilateral del espacio subaracnoideo perioptico en el pseudotumor cerebral con papiledema unilateral. Rev Neurol (Barcelona). 1981;39:11-5. (Pubitemid 11000391)
8. Strominger MB, Weiss GB, Mehler MF. Asymptomatic unilateral papilledema in pseudotumor cerebri. J Clin Neuro Ophthalmol. 1992;12:238-41. (Pubitemid 23001438)
9. Rosenberg M, Huna R, Warren FA, Kupersmith MJ. Unilateral papilledema due to increased intracranial pressure. Invest Ophthalmol Vis Sci. 1996;37:S690. (Pubitemid 126824631)
10. To KW, Warren FA. Unilateral papilledema in pseudotumor cerebri. Arch Ophthalmol. 1990;108:644-5. (Pubitemid 20168817)
11. Hayreh SS. The sheath of the optic nerve. Ophthalmologica (Basel). 1984;189:54-63. (Pubitemid 14033416)
12. Hayreh SS. Pathogenesis of optic disc oedema in raised intracranial pressure. Trans Ophthalmol Soc UK. 1976;96(3):404-7. (Pubitemid 8060307)
13. Hayreh SS, March W, Anderson DR. Pathogenesis of block of rapid orthograde axonal transport by elevated intraocular pressure. Exp Eye Res. 1979;28(5):515-23.
14. Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol. 1977;95(8):1458-62. (Pubitemid 8142315)
15. Wall M, Montgomery EB. Using motion perimetry to detect visual field defects in patients with idiopathic intracranial hypertension: a comparison with conventional automated perimetry. Neurology. 1995;45:1169-75.
16. Tytla ME, Buncic JR. Optic nerve compression impairs low spatial frequency vision in man. Clin Vis Sci. 1988;2:179-86.
17. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974;133:802-7.
18. Johnson LN, Krohel GB, Madsen RW, March Jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998; 105(12):2313-7. (Pubitemid 30191677)
19. Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094-8. (Pubitemid 28212843)
20. Sugerman HJ, Felton 3rd WL, Salvant Jr JB, et al. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45(9):1655-9.
21. Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998;50(4):1099-104. (Pubitemid 28212844)
22. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. Brit Med J. 2010;340:c2701.
23. Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2010.
24. Weisberg LA. Benign intracranial hypertension. Medicine. 1975; 54:197-207.
25. Paterson R, DePasquale N, Mann S. Pseudotumor cerebri. Medicine. 1961;40:85-99.
26. Weisberg LA, Chutorian AM. Pseudotumor cerebri of childhood. Am J Dis Child. 1977;131:1243-8.
27. Gücer G, Vierenstein L. Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg. 1978;49:256-63. (Pubitemid 8379950)
28. Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuro Ophthalmol. 1988;8:93-8.
29. Corbett JJ. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci. 1983;10:221-9. (Pubitemid 14243104)
30. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46(6): 1524-30. (Pubitemid 26185764)
31. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49(3):734-9. (Pubitemid 27428015)
32. Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology. 1993; 43(6):1071-2. (Pubitemid 23177697)
33. Curry Jr WT, Butler WE, Barker 2nd FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery. 2005;57:97-108.
34. Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988;106:1391-7.
35. Sergott RC, Savino PJ, Bosley TM. Optic nerve sheath decompression: a clinical review and proposed pathophysiologic mechanism. Aust New Zeal J Ophthalmol. 1990;18:365-73.
36. Spoor TC, Ramocki JM, Madion MP, Wilkinson MJ. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol. 1991;112:177-85.
37. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1988;106:1378-83.
38. Keltner J. Optic nerve sheath decompression:how does it work? has its time come? Arch Ophthalmol. 1988;106:1378-83.
39. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatr. 1994;57(11):1426-9. (Pubitemid 24342316)
40. Hamed LM, Tse DT, Glaser JS, et al. Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri. Arch Ophthalmol. 1992;110:636-9.
41. Smith CH, Orcutt JC. Surgical treatment of pseudotumor cerebri. Int Ophthalmol Clin. 1986;26:265-75.
42. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111:632-5. (Pubitemid 23143169)
43. Alsuhaibani AH, Carter KD, Nerad JA, Lee A. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2010 Aug 27.
44. Arac A, Lee M, Steinberg GK, et al. Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus. 2009;27(5):E14.
45. Bussière M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2010;31:645-50.
46. Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008;70:641-7. (Pubitemid 351294642)
47. Wall M. Idiopathic intracranial hypertension. In: Lee AG, Brazis PW, ed. Neurologic clinics: neuro-ophthalmology. Elsevier, 2010;28:593-617.
48. Shah VA, Kardon RH, Lee AG, et al. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology. 2008;70(8):634-40. (Pubitemid 351294641)
49. Ahmed R, Wilkinson M, Parker G, Thurtell M, Macdonald J, McCluskey P, Allan R, Dunne V, Hanlon M, Owler B, Halmagyi GM. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 50 patients and of model predictions. Am J Neuroradiol. 2011;32:1408-14.